Biotech Investor Files for Bankruptcy to Protect Startup Funding
A biotech investment company called Apple Tree Partners (ATP) has filed for bankruptcy to make sure its startup companies keep […]
Genetic Testing Companies: What You Need to Know
Even after facing financial troubles, 23andMe had a large amount of personal genetic data from millions of people when it
BeOne’s Blood Cancer Drug Brukinsa Leads the Market, with More Innovations on the Way
BeOne, a Swiss drug company that started in China as BeiGene, is making waves in the blood cancer treatment market.
Former FDA Leaders Worry About New Vaccine Rules
A group of 12 former leaders of the US Food and Drug Administration (FDA) have shared their worries about proposed
Recent setbacks in Alzheimer’s research: What they mean for the future
Recent weeks have seen significant setbacks in the development of new treatments for Alzheimer’s disease. Two promising therapies, one from
Big Changes for UK Pharmacy: What This Means for You
On December 1st, the UK government made a significant change that affects the pharmacy industry. They agreed to a deal
AlzeCure Pharma Gets EUR 2.5 Million Grant for Alzheimer’s Drug Study
AlzeCure Pharma has shared exciting news: they’ve received the first part of a EUR 2.5 million grant from the European
SciNeuro Pharmaceuticals Raises $53 Million to Develop Drugs for Nerve Diseases
A new company called SciNeuro Pharmaceuticals, started in 2020, announced on Thursday that it has raised $53 million to help
Pharmaceutical News
Bristol Myers Squibb’s Breyanzi Gets Fifth US Approval for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s Breyanzi (Lisocabtagene maraleucel) as a treatment for adults
Measles Deaths Drop, But WHO Warns of Ongoing Risks
The World Health Organization (WHO) has shared some good news: deaths from measles have gone down a lot in recent